Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-21-044063

Senior Vice President, Finance sold 293 shares at $35.81 ($10,492)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Senior Vice President, Finance 2021-06-28 Sale −293 $35.81 $10,492 15,577 D
Open-market sales · 293 sh · avg $35.81 · $10,492
Loading xslF345X03/doc4.xml…